ASCO 2026 — McCormick Place, Chicago, United States
The 2026 ASCO Annual Meeting is The Place to Be. Learn more about the sessions, speakers, and science that will be presented at this year's meeting below. Answer who/what/when/where for ASCO 2026 Program pdf with verified dates, location, and what B2B readers should watch. ASCO 2
Presentation data updated Jun 5, 2026, 9:21 AM UTC
- Media coverage 10/20
- Speaker quality 20/20
- Pipeline relevance 2/20
- Historical influence 13/20
- Company participation 14/20
Key Takeaways
Key Themes
Key Companies
Key Drugs
Key Markets
Key Opportunities
Key Data to Watch
Phase III RASolute 303 trial of sotorasib in first-line KRAS G12C-mutated non-small cell lung cancer: early response rate data
Updated overall survival data from the Phase III KEYNOTE-789 trial of pembrolizumab in non-small cell lung cancer
Phase III data of sacituzumab tirumotecan in triple-negative breast cancer
Updated results from the open-label Phase I/Ib CHRYSALIS-2 study (NCT04077463) of amivantamab and lazertinib in non-small cell lung cancer
Phase II data of pumitamig in relapsed/refractory multiple myeloma
Data for sacituzumab tirumotecan in lung cancer
Phase I data of silevertinib in EGFR-mutant non-small cell lung cancer